These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36220421)

  • 1. Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not.
    Musil D
    Vnitr Lek; 2022; 68(4):234-239. PubMed ID: 36220421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
    Gianesini S; De Luca L; Feodor T; Taha W; Bozkurt K; Lurie F
    Adv Ther; 2023 Dec; 40(12):5137-5154. PubMed ID: 37768506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
    Ulloa JH
    Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LivRelief varicose veins cream in the treatment of chronic venous insufficiency of the lower limbs: A 6-week single arm pilot study.
    Dwyer HC; Baranowski DC; Mayer PV; Gabriele S
    PLoS One; 2018; 13(12):e0208954. PubMed ID: 30596677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis.
    Bignamini AA; Matuška J
    Adv Ther; 2020 Mar; 37(3):1013-1033. PubMed ID: 31989486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence.
    Davies AH
    Adv Ther; 2019 Mar; 36(Suppl 1):5-12. PubMed ID: 30758738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of venoactive substances in phlebology. Treatment of varicose veins and post-thrombotic syndrome].
    Rudofsky G
    Fortschr Med; 1986 Dec; 104(47-48):963-4. PubMed ID: 3817710
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulodexide: it is time for a program against chronic venous disease.
    Roztocil K; Antignani PL
    Int Angiol; 2014 Jun; 33(3):209-11. PubMed ID: 24936530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present and future in the management of venous vascular diseases].
    Gavorník P; Dukát A; Gašpar Ľ; Gavorníková E
    Vnitr Lek; 2015 Feb; 61(2):151-6. PubMed ID: 25813260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease.
    Mannello F; Ligi D; Raffetto JD
    Int Angiol; 2014 Jun; 33(3):236-42. PubMed ID: 24936532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: a systematic review.
    Mansilha A; Sousa J
    Int Angiol; 2019 Aug; 38(4):291-298. PubMed ID: 31284708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CVD: a condition of underestimated severity.
    Lattimer CR
    Int Angiol; 2014 Jun; 33(3):222-8. PubMed ID: 24732585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema.
    Allaert FA
    Int Angiol; 2012 Aug; 31(4):310-5. PubMed ID: 22801396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of deep venous varicose insufficiency].
    Petter O
    Phlebologie; 1992; 45(3):247-53; discussion 253-4. PubMed ID: 1470647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of chronic venous insufficiency in 895 patients followed in general practice.
    Boccalon H; Janbon C; Saumet JL; Tafani A; Roux T; Vilain C
    Int Angiol; 1997 Dec; 16(4):226-34. PubMed ID: 9543218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence.
    Nicolaides AN; Allegra C; Bergan J; Bradbury A; Cairols M; Carpentier P; Comerota A; Delis C; Eklof B; Fassiadis N; Georgiou N; Geroulakos G; Hoffmann U; Jantet G; Jawien A; Kakkos S; Kalodiki E; Labropoulos N; Neglen P; Pappas P; Partsch H; Perrin M; Rabe E; Ramelet AA; Vayssaira M; Ioannidou E; Taft A
    Int Angiol; 2008 Feb; 27(1):1-59. PubMed ID: 18277340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of Detravenol in treatment of chronic venous insufficiency of lower limbs].
    Ponomarev ÉA; Strepetov NN; Sotnikov IE; Vasil'ev SV; Arnautov VS; Kasatkina IS; Bukhtenkov AV
    Angiol Sosud Khir; 2020; 26(2):95-102. PubMed ID: 32597889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.